Not applicableStudy completedNCT03205306What this trial is testingMyasthenia Gravis and PsycheWho this might be right forMyasthenia Gravis Charite University, Berlin, Germany 1,399
Not applicableStudy completedNCT03571555What this trial is testingProspective Cohort Study of Adolescents Living With HIV and Their Caregivers Attending a Psychosocial Programme in BotswanaWho this might be right forHiv Royal Holloway University 516
Early research (Phase 1)Study completedNCT01357213What this trial is testingPhase 1 PK Study of XOMA 3ABWho this might be right forBotulism National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT05890833What this trial is testingThe Risk of Falls Index for Patients With Neuromuscular DisordersWho this might be right forInclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular Dystrophies+3 more LMU Klinikum 30
Not applicableLooking for participantsNCT07570589What this trial is testingMonitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Who this might be right forGeneralized Myasthenia Gravis Centre Hospitalier Universitaire de Nice 50
Large-scale testing (Phase 3)Study completedNCT05615025What this trial is testingInfluence of Sevoflurane and Propofol on Maximum Muscular Strength, Speed of Contraction and RelaxationWho this might be right forAnesthesia, GeneralNeuromuscular Transmission Disorders Brugmann University Hospital 48
Large-scale testing (Phase 3)Study completedNCT05514873What this trial is testingAn Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 InhibitorsWho this might be right forGeneralized Myasthenia Gravis UCB Biopharma SRL 26
Early research (Phase 1)Not Yet RecruitingNCT07676266What this trial is testingC-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard TherapyWho this might be right forMultiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more The Affiliated Hospital of Qingdao University 18
Not applicableStudy completedNCT03049956What this trial is testingOVEMP in MyastheniaWho this might be right forMyasthenia Gravis, Ocular University of Zurich 96
Early research (Phase 1)Study completedNCT02779140What this trial is testingPhase I, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1632Who this might be right forBotulism National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableActive Not RecruitingNCT05150210What this trial is testingSP Thoracic IDE StudyWho this might be right forPrimary Lung CancerBenign Lung DiseaseThymoma+1 more Intuitive Surgical 32
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)WithdrawnNCT00723918What this trial is testingCombination of an Investigational Cannabinoid and Methadone for HIV-associated NeuropathyWho this might be right forHIV-associated NeuropathyPolyneuropathy Washington University School of Medicine
Early research (Phase 1)WithdrawnNCT04965987What this trial is testingOxaloacetate in Myasthenia GravisWho this might be right forMyasthenia Gravis University of Kansas Medical Center
Large-scale testing (Phase 3)Study completedNCT00232141What this trial is testingStudy of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV NeuropathyWho this might be right forHIV InfectionsPeripheral Neuropathy Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 302
Testing effectiveness (Phase 2)Active Not RecruitingNCT06282159What this trial is testingEvaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)Who this might be right forMyasthenia Gravis, Generalized Dianthus Therapeutics 65
Large-scale testing (Phase 3)Study completedNCT00309101What this trial is testingAn Open Study for Steroid Resistant, Non-Thymectomized MG PatientsWho this might be right forMyasthenia Gravis Astellas Pharma Inc 11
Testing effectiveness (Phase 2)Study completedNCT03315130What this trial is testingSafety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia GravisWho this might be right forGeneralized Myasthenia Gravis Ra Pharmaceuticals 45
Early research (Phase 1)Looking for participantsNCT07526493What this trial is testingSafety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.Who this might be right forMultiple Sclerosis (MS)Neuromyelitis Optica Spectrum Disorder (NMOSD)Autoimmune Encephalitis (AE)+4 more Tongji Hospital 6
Large-scale testing (Phase 3)Looking for participantsNCT07249632What this trial is testingTelitacicept in Patients With Ocular Myasthenia Gravis (OMG)Who this might be right forMyasthenia Gravis, Ocular RemeGen Co., Ltd. 120